Compare · ISRG vs XPEL
ISRG vs XPEL
Side-by-side comparison of Intuitive Surgical Inc. (ISRG) and XPEL Inc. (XPEL): market cap, price performance, sector, and recent activity on the wire.
Summary
- ISRG operates in Health Care, while XPEL operates in Industrials - the two are in different parts of the market.
- ISRG is the larger of the two at $148.26B, about 119.9x XPEL ($1.24B).
- Over the past year, ISRG is down 20.4% and XPEL is up 19.5% - XPEL leads by 40.0 points.
- ISRG has been more active in the news (7 items in the past 4 weeks vs 2 for XPEL).
- ISRG has more recent analyst coverage (25 ratings vs 3 for XPEL).
- Company
- Intuitive Surgical Inc.
- XPEL Inc.
- Price
- $418.56-0.84%
- $44.98+1.12%
- Market cap
- $148.26B
- $1.24B
- 1M return
- -7.66%
- +2.34%
- 1Y return
- -20.43%
- +19.53%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2000
- News (4w)
- 7
- 2
- Recent ratings
- 25
- 3
Intuitive Surgical Inc.
Intuitive Surgical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets da Vinci surgical systems, and related instruments and accessories in the United States and internationally. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D HD vision systems, skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures. It also manufactures EndoWrist instruments, such as forceps, scissors, electrocautery tools, scalpels, and other surgical tools, which incorporate wrist joints for natural dexterity for various surgical procedures; and provides SimNow, a cloud-enabled simulation platform, which allows surgeons to learn and practice their surgical skills; Iris, an augmented reality imaging product for use in kidney procedures; and Intuitive Cloud that enables proactive monitoring and software updates. In addition, the company offers EndoWrist Stapler, a wristed stapling instrument for resection, transection, and creation of anastomoses; EndoWrist One Vessel Sealers that are wristed single-use instruments for bipolar coagulation and mechanical transection of vessels up to 7mm in diameter and tissue bundles that fit in the jaws of the instrument; E-100 generator, an electrosurgical generator; SureForm 45 Curved-Tip stapler; and SynchroSeal for sealing and transection with a single pedal press. Additionally, the company sells various accessories comprising sterile drapes for ensuring sterile field during surgery; and vision products that include replacement 3D stereo endoscopes, camera heads, light guides, and other items that facilitate the use of the da Vinci Surgical System, as well as Ion endoluminal system for biopsies. Intuitive Surgical, Inc. was founded in 1995 and is headquartered in Sunnyvale, California.
XPEL Inc.
XPEL, Inc. manufactures, sells, distributes, and installs after-market automotive products in the United States, China, Canada, Continental Europe, the United Kingdom, Asia Pacific, Latin America, the Middle East/Africa, and internationally. The company offers automotive surface and paint protection, headlight protection, and automotive and architectural window films, as well as proprietary software. It also provides merchandise and apparel, and ceramic coatings. In addition, the company offers paint protection kits, car wash products, after-care products, and installation tools through its website. It sells its products to independent installers and new car dealerships, third party distributors, owned installation centers, and franchisees and online. The company was founded in 1997 and is headquartered in San Antonio, Texas.
Latest ISRG
- SVP & GM da Vinci Platforms & Jeddi Iman sold $2,365,594 worth of shares (5,625 units at $420.55) as part of a pre-agreed trading plan and exercised 5,625 shares at a strike of $77.00 (SEC Form 4)
- Intuitive Surgical Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- Intuitive Announces New Chief Commercial and Marketing Officer Taylor Patton
- EVP & Chief Mfg and Supply Cha Brosius Mark sold $15,945 worth of shares (36 units at $442.92) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 1,523 units (SEC Form 4)
- SEC Form SD filed by Intuitive Surgical Inc.
- Intuitive Announces Innovations to Advance Quintuple Aim
- EVP & Chief Mfg and Supply Cha Brosius Mark sold $23,464 worth of shares (54 units at $434.52) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 1,559 units (SEC Form 4)
- EVP & Chief Legal and Complian Loeb Gary sold $178,780 worth of shares (400 units at $446.95) as part of a pre-agreed trading plan, decreasing direct ownership by 6% to 6,120 units (SEC Form 4)
- Intuitive Surgical Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits
- SEC Form 4 filed by Director Guthart Gary S
Latest XPEL
- XPEL Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial Obligation, Regulation FD Disclosure, Financial Statements and Exhibits
- XPEL Announces Approximately $110 Million Manufacturing and Supply Chain Investment, Including Expansion of San Antonio Operations and Acquisition of Manufacturing Facility in China
- Amendment: SEC Form SCHEDULE 13G/A filed by XPEL Inc.
- XPEL Marks Skin Cancer Awareness Month and National Don't Fry Day with Limited-Time Window Tint Offer to Help Drivers Beat Heat and UV Exposure
- SEC Form 10-Q filed by XPEL Inc.
- XPEL Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- XPEL Reports Revenue Growth of 13.1% to $117.4 million, EBITDA Growth of 17.8% to $17.0 million in First Quarter 2026
- SEC Form 3 filed by new insider Thornton Mark Andrew
- SEC Form DEFA14A filed by XPEL Inc.
- SEC Form DEF 14A filed by XPEL Inc.